Maze Therapeutics (MAZE) EBITDA (2024 - 2026)
Maze Therapeutics (MAZE) reported EBITDA of -$26.6 million for Q1 2026, up 24.99% on a YoY basis from -$21.2 million in Q1 2025, and up 30.23% sequentially from -$38.1 million in Q4 2025.
Maze Therapeutics (MAZE) EBITDA (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of EBITDA data on file, last reported at -$26.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 24.99% year-over-year to -$26.6 million; the trailing twelve-month figure through Mar 2026 stood at -$134.1 million (down 367.04% YoY), and the FY2025 full-year result was -$142.9 million, down 348.15% from the prior year.
- EBITDA rose to -$26.6 million in Q1 2026, from -$38.1 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $139.6 million in Q2 2024 to a low of -$38.1 million in Q4 2025.
- A 3-year average of -$12.4 million and a median of -$29.7 million in 2024 frame the typical range for EBITDA.
- Across the five-year window, EBITDA tumbled 126.14% in 2025 and grew 24.99% in 2026, its largest moves.
- Tracing MAZE's EBITDA over 3 years: stood at -$29.7 million in 2024, then dropped by 28.03% to -$38.1 million in 2025, then soared by 30.23% to -$26.6 million in 2026.
- Business Quant data shows MAZE's EBITDA at -$26.6 million in Q1 2026, -$38.1 million in Q4 2025, and -$33.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | -26.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.55 Mn |
| Dec 31, 2025 | -38.06 Mn |
| Sep 30, 2025 | -32.97 Mn |
| Jun 30, 2025 | -36.47 Mn |
| Mar 31, 2025 | -35.40 Mn |
| Dec 31, 2024 | -29.73 Mn |
| Sep 30, 2024 | -24.23 Mn |
| Jun 30, 2024 | 139.56 Mn |
| Mar 31, 2024 | -28.01 Mn |